alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
32.1

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Apria
Healthcare Group Inc. (the company or Apria) on Form 10-Q for
the quarter ended June 30, 2004 as filed with the SEC on the date hereof (the
Report), I, Lawrence M. Higby, Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ LAWRENCE M. HIGBY Lawrence M. Higby
Chief Executive OfficerAugust 6, 2004

A signed original of this written statement required by
Section 906 has been provided to Apria and will be retained by Apria and furnished to the
Securities and Exchange Commission or its staff upon request.
**Exhibit 31.1****CERTIFICATIONS**I, Steven A. Kriegsman, Chief Executive Officer of CytRx Corporation, certify that:1. I have reviewed this annual report on Form 10-K of CytRx Corporation;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisannual report;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the period presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forthe registrant and have:     (a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;     (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and     (c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions):     (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and     (b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.   Date: March 30, 2006 /s/ STEVEN A. KRIEGSMAN     Steven A. Kriegsman  Chief Executive Officer
I 

117TH CONGRESS 

1ST SESSION H. R. 1293 

To amend the Help America Vote Act of 2002 to prohibit a State from 

counting a ballot cast in an election for Federal office which is received 

by the State after the date of the election. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 24, 2021 

Mr. GOHMERT introduced the following bill; which was referred to the 

Committee on House Administration 

A BILL 

To amend the Help America Vote Act of 2002 to prohibit 

a State from counting a ballot cast in an election for 

Federal office which is received by the State after the 

date of the election. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PROHIBITING COUNTING BALLOTS RECEIVED 

4 AFTER DATE OF ELECTION. 

5 (a) PROHIBITION.—Title III of the Help America 

6 Vote Act of 2002 (52 U.S.C. 21081 et seq.) is amended 

7 by inserting after section 303 the following new section: 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 1293 IH

1 ‘‘SEC. 303A. PROHIBITING COUNTING OF BALLOTS RE2 CEIVED AFTER DATE OF ELECTION. 

3 ‘‘(a) PROHIBITION.—A State may not count a ballot 

4 cast in an election for Federal office which is received by 

5 the State after the date of the election. For purposes of 

6 this subsection, a ballot shall be considered to be received 

7 by the State after the date of the election if the ballot 

8 is not received by the appropriate State or local election 

9 official prior to 12:01 a.m. on the day after the date of 

10 the election. 

11 ‘‘(b) EXCEPTION FOR ABSENT UNIFORMED SERV12 ICES VOTERS AND OVERSEAS CITIZENS.—Subsection (a) 

13 does not apply with respect to any individual who is enti14 tled to vote by absentee ballot under the Uniformed and 

15 Overseas Citizens Absentee Voting Act (52 U.S.C. 20301 

16 et seq.). 

17 ‘‘(c) EFFECTIVE DATE.—This section shall apply 

18 with respect to elections for Federal office held on or after 

19 the date of the enactment of this section.’’. 

20 (b) CONFORMING AMENDMENT RELATING TO EN21 FORCEMENT.—Section 401 of such Act (52 U.S.C. 21111) 

22 is amended by striking ‘‘and 303’’ and inserting ‘‘303, and 

23 303A’’. 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 1293 IH

1 (c) CLERICAL AMENDMENT.—The table of contents 

2 of such Act is amended by inserting after the item relating 

3 to section 303 the following new item: 

‘‘Sec. 303A. Prohibiting counting of ballots received after date of election.’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
IN THE SUPREME COURT OF PENNSYLVANIA WESTERN DISTRICT TONI BRACKEN, ADMINISTRATRIX OF THE ESTATE OF WILLIAM BRACKEN, DECEASED

v. BURCHICK CONSTRUCTION COMPANY, INC., PATENT CONSTRUCTION COMPANY AND HARSCO CORPORATION. PETITION OF: KUSLER MASONRY, INC. : : : : : : : : : : : : : : : No. 8 WAL 2015 Petition for Allowance of Appeal from the Order of the Superior Court

ORDER PER CURIAM AND NOW , this 29th day of July, 2015, the Petition for Allowance of Appeal is DENIED

.
List of Documents Submitted by the State of Hawaii
exv10w61






Exhibit 10.61




December 26, 2008




Luke Seikkula




[Address]




Re:      First Amendment to Offer of Employment




Dear Luke:




     This letter amends the terms of the Offer of Employment (the “Agreement”) dated as of March
4, 2008, by and between La
Jolla Pharmaceutical Company (“LJPC”) and you as set forth below.
Capitalized terms not defined herein shall have the meaning specified in the Agreement.



     1. The seventh paragraph of the Agreement is hereby deleted in its entirety and replaced
with the following:




“If your employment is terminated by Company for other than Cause, you will receive a severance
amount equal to 6 months of your then current base salary, which will be paid on the first payroll
date that occurs 30 days after the date of termination of service, provided you sign a
separation agreement in a form acceptable to Company, including a complete release of claims within
21 days of the date of termination of service and you do not revoke the release. For purposes of
this offer letter, “Cause” shall mean your employment is terminated for dishonesty, misconduct,
failure or inability to perform your job duties (with reasonable accommodation, if required by
law), or other conduct that has a material adverse effect on the name or public image of Company.”



     2. Except as amended herein, the Agreement is hereby confirmed in all other respects and
nothing contained herein shall be deemed a waiver of any right or abrogation of any obligation
otherwise existing under the Agreement except to the extent specifically provided for herein.



 









 





Luke Seikkula

Page 2




     Please indicate your acceptance of this amendment to the Agreement by signing the enclosed copy of
this letter and returning it to me.



	 	 	 	 	 
	 	 	La Jolla Pharmaceutical Company
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Deirdre Y. Gillespie, M.D.
	 

	 	 	 	 
	 

	 	Name:
	 	Deirdre Y. Gillespie, M.D.
	 

	 	Title:
	 	President and Chief Executive Officer






	 	 	 
	Accepted
and agreed: 
	 	 
	 
	 	 
	/s/
Luke Seikkula        26 Dec 08


 

Luke Seikkula
EX PARTE Robert BROWN

CR-16-0105

Court of Criminal Appeals of Alabama.

February 1, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Mand. pet. dismissed.
#### UNITED STATES of America, Plaintiff-Appellee, v. Robert MORRISON, Defendant-Appellant.

No. 03-30323.

United States Court of Appeals, Ninth Circuit.

Submitted May 10, 2004.*

Decided May 19, 2004.

Aaron N. Lucoff, Esq., USBO — Office of the U.S. Attorney, Boise, ID, for PlaintiffAppellee.

Mark S. Moorer, Esq., Moscow, ID, for Defendant-Appellant.

Before: CANBY, KOZINSKI and PAEZ, Circuit Judges.

*

 This panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Robert Morrison appeals his jury conviction and 85-month sentence for conspiracy to distribute, and distribution of, methamphetamine, in violation of 21 U.S.C. §§ 841 and 846.

Morrison contends that he received ineffective assistance of trial counsel at various stages of the proceedings in district court. “Ineffective assistance of counsel claims are generally inappropriate on direct appeal[, but] ... *may*nevertheless be reviewed on direct appeal in two circumstances: ‘1) when the record on appeal is sufficiently developed to permit review and determination of the issue, or 2) when the legal representation is so inadequate that it obviously denies a defendant his Sixth Amendment right to counsel.’” *United States v. Lillard,*354 F.3d 850, 856 (9th Cir.2003) (emphasis added). Because neither circumstance is present in this case, we decline to address Morrison’s ineffective assistance of counsel claims. *Cf. Massaro v. United States,*538 U.S. 500, 123 S.Ct. 1690, 1694, 155 L.Ed.2d 714 (2003) (noting that it is preferable to bring inef*764fective assistance claims in a 28 U.S.C. § 2255 motion in order to allow “additional factual development” concerning the actions taken or omitted by counsel).

AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
Huascar HAWKINS, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3994

District Court of Appeal of Florida, Fifth District.

Decision filed March 27, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Exhibit 32.1

                               CERTIFICATION UNDER
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Glacier Water Services, Inc.,
(the Company) on Form 10-Q for the Quarter ended June 27, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Brian H.
McInerney, President and Chief Executive Officer of the Company, certify,
pursuant to and for the purposes of 18 U.S.C. ss. 1350, as adopted pursuant to
ss. 906 of the Sarbanes-Oxley Act of 2002, that:

        (1)     The Report fully complies with the  requirements of section
                13(a) or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information contained in the Report fairly presents, in all
                material respects, the financial condition of the Company as of
                the dates indicated and results of operations of the Company
                for the periods indicated.


/s/ Brian H. McInerney

Brian H. McInerney
President and Chief Executive Officer
August 4, 2004
[Federal Register Volume 87, Number 23 (Thursday, February 3, 2022)]
[Notices]
[Page 6180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02252]


-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4393-DR; Docket ID FEMA-2022-0001]


North Carolina; Amendment No. 14 to Notice of a Major Disaster 
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration 
for the State of North Carolina (FEMA-4393-DR), dated September 14, 
2018, and related determinations.

DATES: This change occurred on January 18, 2022.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and 
Recovery, Federal Emergency Management Agency, 500 C Street SW, 
Washington, DC 20472, (202) 646-2833.

SUPPLEMENTARY INFORMATION: The Federal Emergency Management Agency 
(FEMA) hereby gives notice that pursuant to the authority vested in the 
Administrator, under Executive Order 12148, as amended, Kevin A. 
Wallace, of FEMA is appointed to act as the Federal Coordinating 
Officer for this disaster.
    This action terminates the appointment of Myra M. Shird as Federal 
Coordinating Officer for this disaster.

    The following Catalog of Federal Domestic Assistance Numbers 
(CFDA) are to be used for reporting and drawing funds: 97.030, 
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis 
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster 
Unemployment Assistance (DUA); 97.046, Fire Management Assistance 
Grant; 97.048, Disaster Housing Assistance to Individuals and 
Households In Presidentially Declared Disaster Areas; 97.049, 
Presidentially Declared Disaster Assistance--Disaster Housing 
Operations for Individuals and Households; 97.050, Presidentially 
Declared Disaster Assistance to Individuals and Households--Other 
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially 
Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2022-02252 Filed 2-2-22; 8:45 am]
BILLING CODE 9111-23-P
Order entered September 2 6 . 2022

In The 

### Court of Appeals Fifth District of Texas at Dallas
No. 05
- 22
- 00465
- CR
ROYAL DOUGLAS ROBINSON , Appellant

V. THE STATE OF TEXAS , Appellee On Appeal from the 291st Judicial District Court

Dallas County, Texas Trial Court Cause No. F16
- 00017
- U

O RDER Before the Court is appellant ’ s September 21, 2022 pro se motion requesting leave to file appellant ’ s second m otion for extension of time to file his brief. By

or der entered September 14, 2022, t he Court ordered appellant ’ s tendered brief
f iled as of that date. Accordingly, we DENY AS MOOT appellant ’ s motion seeking leave to file for a second extension on his brief.

/s/ ROBERT D. BURNS, III CHIEF JUSTICE
To: Federal Aviation Administration

From: Robert G Breese Subject: Petition For Exemption Title 14 CFR Date: October 14, 2015

Dear Sir/Madam,

I am filing this petition for exemption so I may follow all rules and guidelines set forth by your organization pertaining to the use of my DJI Phantom 3 Professional drone. I am not quite sure if I fall into the “commercial use” category but thought I was better safe then sorry. Having been a police officer for twenty seven years and retiring as a Captain I have always strived to uphold the law. After retiring in 2006 I became an avid photographer. As the years progressed I expanded my photography equipmen t to include various high end cameras and lense s as well as computers and photoshop software. Most of my work includes scenic landscape images from my home town of Warwick NY. I also shoot in other areas of the Hudson Valley NY. Editors of various newspap ers and magazines saw my work and asked if I would do freelance photography for them from time to time. I have been doing this for several years now. Several months ago I purchased the above mentioned drone and have used it many times. Keeping in mind the safety guidelines set forth by the FAA. The drone/camera is another piece of photography equipment to give the readers and public a different perspective of many of the same areas covered by ground for years. No one was able to get aerial photos but the r ichest of photographers who could afford to rent a plane for a few hours. The public is very interested in the still and video photography I have produced of working farms to everyday life in the Village of Warwick NY. All the time maintaining the safety needed during the proper operation of this UAV. Any place I have used this equipment there has always been a huge interest in this technology. There is great public interest in the photos and videos it produces. Although photography is still my main hobby in retirement some of my work gets published generating a small amount of money for me. I have not received any money for a drone photo yet but I am sure it will probably happen at some point in the future. Does this require an exemption or is it covered under hobbyist? Any help on this matter would be greatly appreciated. Thank you Robert G Breese 12Annabelle Lane Warwick, NY 10990 Email: RGB319@gmail.com Phone: 845

- 242

- 5918
I 

117TH CONGRESS 

1ST SESSION H. R. 1169 

To prohibit all United States assessed and voluntary contributions to the 

United Nations until such time as the membership in the United Nations 

of the People’s Republic of China is terminated and the Republic of 

China (Taiwan) is afforded full rights, privileges, and responsibilities 

as a Member State in the United Nations, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 18, 2021 

Mr. PERRY introduced the following bill; which was referred to the Committee 

on Foreign Affairs 

A BILL 

To prohibit all United States assessed and voluntary contributions to the United Nations until such time as the 

membership in the United Nations of the People’s Republic of China is terminated and the Republic of China 

(Taiwan) is afforded full rights, privileges, and responsibilities as a Member State in the United Nations, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Taiwan Voice Act’’. 


ctelli on DSK11ZRN23PROD with BILLS
2 

•HR 1169 IH

1 SEC. 2. MEMBERSHIP OF TAIWAN AT THE UNITED NATIONS. 

2 (a) IN GENERAL.—Notwithstanding any other provi3 sion of law, effective on the date of the enactment of this 

4 Act, the United States shall withhold all assessed and vol5 untary contributions to the United Nations until such time 

6 as the membership of the People’s Republic of China in 

7 the World Health Organization is terminated and the Re8 public of China (Taiwan) is afforded full rights, privileges, 

9 and responsibilities as a Member State in the United Na10 tions. 

11 (b) PRESIDENTIAL ACTION.—The President is au12 thorized to take any appropriate action to carry out sub13 section (a). 

14 (c) ACTIONS AT THE WORLD HEALTH ORGANIZA15 TION.—The President shall direct the United States rep16 resentative to the World Health Organization to use the 

17 voice, vote, and influence of the United States at the 

18 World Health Organization to encourage Members States 

19 of the United Nations to take actions identical or similar 

20 to the action described in subsection (a). 

21 (d) NO EFFECT ON THE UNITED STATES IN THE

22 WORLD HEALTH ORGANIZATION.—United States mem23 bership in the United Nations shall not be affected in any 

24 way by any action under this section. 

Æ 


ctelli on DSK11ZRN23PROD with BILLS
# Fourth Court of Appeals

San Antonio, Texas

May 8, 2015

N o. 04

- 15

- 00212

- CV

IN THE INTEREST OF R.K.H., A CHILD,

Fr om the 224th Judicial District Court, Bexar County, Texas

Trial Court No. 2012

- PA

- 01466

Honorable Janet P. Littlejohn, Judge Presiding



### O R D E R

This is an accelerated appeal of an order terminating appellant’s parental rights. We

ORDER court reporter Victoria Gonzalez to file the reporter’s record on or before May 18, 2015.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 8th day of Ma y, 2015

.

______ _____________________________ Keith E. Hottle

Clerk of Court
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1186 Introduced in House (IH)]

<DOC>

117th CONGRESS
  1st Session
                                H. R. 1186

To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat 
 of counterfeit drugs to the pharmaceutical supply chain, and to make 
    the pharmaceutical supply chain more robust, while ensuring the 
  authenticity, content, purity, and manufacturing location and batch 
  number of drugs (including COVID-19 therapeutics and vaccines) and 
 allowing patient verification of authenticity, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 18, 2021

Mr. Van Drew (for himself and Mr. Baird) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat 
 of counterfeit drugs to the pharmaceutical supply chain, and to make 
    the pharmaceutical supply chain more robust, while ensuring the 
  authenticity, content, purity, and manufacturing location and batch 
  number of drugs (including COVID-19 therapeutics and vaccines) and 
 allowing patient verification of authenticity, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Supply Chain Security and 
Pharmaceutical Authentication Act of 2021''.

SEC. 2. PACKAGES SUBJECT TO PHARMACEUTICAL DISTRIBUTION SUPPLY CHAIN 
              REQUIREMENTS.

    Subparagraph (B) of section 581(11) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360eee(11)) is amended to read as follows:
                    ``(B) Individual saleable unit.--For purposes of 
                this paragraph, an `individual saleable unit' is the 
                smallest solid oral dosage form of product, or other 
                individual solid oral dosage form of product, 
                introduced into commerce by the manufacturer or 
                repackager.''.
                                 <all>
```
STATE of Louisiana v. Tyrone Lentrell POPE

NO. 2017-K-1744

Supreme Court of Louisiana.

June 1, 2018

Denied.